“Grandfathered” Category Of “Convenience-Size” OTCs Sought By GSK
This article was originally published in The Tan Sheet
Executive Summary
FDA's rule partially delaying implementation of OTC labeling requirements for certain "convenience-size" drugs should be amended to include a category of "grandfathered" products, GlaxoSmithKline says in an Oct. 25 citizen petition
You may also be interested in...
OTC “Convenience-Size” Two-Dose Rule Should Allow For Exemptions – CHPA
FDA should extend its classification of "convenience-size" OTCs beyond the two-dose limit outlined in a recent rule partially delaying "Drug Facts" labeling compliance for such products, the Consumer Healthcare Products Association says
OTC Labeling Compliance Date Delayed For “Convenience-Size” Items
"Convenience-size" OTC drugs will not be required to meet "Drug Facts" reg compliance dates until FDA publishes either a final rule or further notice on the labeling of such products
Block Exemption Request Differentiates "Label" From "Labeling"
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder complies with provisions of the FD&C Act that differentiate a product's "label" from product "labeling," the company says in a Dec. 22 letter to FDA.